Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
Home
Publications
Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
Authors:
CA
Clare M. Adams
Clare M. Adams
RM
Ramkrishna Mitra
Ramkrishna Mitra
YX
Youcai Xiao
Youcai Xiao
PM
Peter Michener
Peter Michener
JP
Juan Palazzo
Juan Palazzo
AC
Allen Chao
Allen Chao
JG
Jitendra Gour
Jitendra Gour
JC
Joel Cassel
Joel Cassel
JS
Joseph M. Salvino
Joseph M. Salvino
CE
Christine M. Eischen
Christine M. Eischen
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
11 December 2025
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/2159-8290.30859506
Abstract
Supplementary Materials and Methods, Tables S1-S3, Figures S1-S7
Keywords
BREAST CANCER
CELL DEATH AND SENESCENCE
TRANSCRIPTIONAL CONTROL OF APOPTOSIS
DRUG TARGETS
ONCOPROTEIN & TUMOR SUPPRESSOR DRUG TARGETS
ONCOGENES & TUMOR SUPPRESSORS
TP53
Related articles
Scroll to top